2011Xiandai shengwu yixue jinzhanRequires access

Pharmacological Prophylaxis of Acute Mountain Sickness

Jianbo Wang

Open publisher page 3 citations

Abstract

Acute mountain sickness(AMS) is defined as the presence of a combination of nonspecific symptoms that appear within a few hours after ascent to altitude,eg,headache,loss of appetite,nausea,vomiting,weakness,lassitude,dizziness,and difficulty sleeping.Increases in severity of symptoms or signs of neurological dysfunction(ataxia or altered consciousness) indicate transition to a life-threatening form of altitude illness.High-altitude cerebral edema(HACE) and high-altitude pulmonary edema(HAPE),2 forms of high altitude illness that are potentially lethal.As increasing numbers of people choose to sojourn or work to the mountains,high-altitude illness is becoming a pathological phenomenon about which healthcare providers should have greater awareness.In order to help people find the most efficient and fastest way to prevent the AMS,we introduced several drugs which have already worked out during the clini-cal use.There are also some medicine which have potential effect have been showed in this view.

About this research paper

What this paper is about

Acute mountain sickness(AMS) is defined as the presence of a combination of nonspecific symptoms that appear within a few hours after ascent to altitude,eg,headache,loss of appetite,nausea,vomiting,weakness,lassitude,dizziness,and difficulty sleeping.Increases in severity of symptoms or signs of neurological dysfunction(ataxia or altered consciousness) indicate transition to a life-threatening form of altitude illness.High-altitude cerebral edema(HACE) and high-altitude pulmonary edema(HAPE),2 forms of high altitude illness that are potentially lethal.As increasing numbers of people choose to sojourn or work to the mountains,high-altitude illness is becoming a pathological phenomenon about which healthcare providers should have greater awareness.In order to help people find the most efficient and fastest way to prevent the AMS,we introduced several drugs which have already worked out during the clini-cal use.There are also some medicine which have potential effect have been showed in this view.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Acute mountain sickness(AMS) is defined as the presence of a combination of nonspecific symptoms that appear within a few hours after ascent to altitude,eg,headache,loss of appetite,nausea,vomiting,weakness,lassitude,dizziness,and difficulty sleeping.Increases in severity of symptoms or signs of neurological dysfunction(ataxia or altered consciousness) indicate transition to a life-threatening form of altitude illness.High-altitude cerebral edema(HACE) and high-altitude pulmonary edema(HAPE),2 forms of high altitude illness that are potentially lethal.As increasing numbers of people choose to sojourn or work to the mountains,high-altitude illness is becoming a pathological phenomenon about which healthcare providers should have greater awareness.In order to help people find the most efficient and fastest way to prevent the AMS,we introduced several drugs which have already worked out during the clini-cal use.There are also some medicine which have potential effect have been showed in this view.

Key concepts: Nausea, Effects of high altitude on humans, Medicine, Vomiting, Altitude sickness, High-altitude pulmonary edema, Ataxia, Weakness

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacological Prophylaxis of Acute Mountain Sickness — Research Paper | ScholarLens